Clinical Trial Update: Flotufolastat F 18 PET in Men With Very Low PSA Recurrence

View source ↗

Summary

This clinical trial update notes that a study evaluating Flotufolastat F-18 PET imaging for men with very low PSA recurrence of prostate cancer is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Flotufolastat F-18 (flotufolastat F-18)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Prostate Cancer (Adenocarcinoma), Prostate Specific Antigen | Status: RECRUITING